Quote:
Originally Posted by reverett123
My money is betting that they are talking about Exendine-4 that Tom Isaacs is flogging gila monsters to produce. I found a corporate presentation for investors from early this year at pharmain.com/pdfs/Non- ConfidentialTechnologyPresentation.pdf
Download and look at the last three or four pages. Among other interesting tid bits are "PGC protects GLP-1 from DPP-IV degradation". That is exactly what Tom and crew are into. GLP-1 is the peptide that rebuilds the brain and DPP-IV is the enzyme that prevents it from working. |
Wow. Hadn't heard of this potential treatment. Tom must be doing something right; it looks like clinical trials (pilot study) on Exendin-4 for PD is now recruiting participants in the UK. This would move through FDA hoops so much the sooner.
Exendin-4 as a Treatment for Parkinson's